| 发明名称 |
Combination Use of CD47 Antibodies/Inhibitors with Sorafenib for Treatment of Liver Cancer |
| 摘要 |
The subject invention pertains to methods, and related compositions, for treating or inhibiting liver cancer, comprising administering an effective amount of sorafenib; and an inhibiting agent selected from a CD47 inhibiting agent, a NF-κB inhibiting agent, and combination thereof. |
| 申请公布号 |
US2017071918(A1) |
申请公布日期 |
2017.03.16 |
| 申请号 |
US201514856137 |
申请日期 |
2015.09.16 |
| 申请人 |
THE UNIVERSITY OF HONG KONG |
发明人 |
Ng Lui Oi Lin Irene;Lee Terence Kin Wah |
| 分类号 |
A61K31/44;A61K31/167;A61K39/395 |
主分类号 |
A61K31/44 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method for treating or inhibiting liver cancer, comprising administering to a subject in need thereof an effective amount of:
sorafenib; and an inhibiting agent selected from a CD47 inhibiting agent, a NF-κB inhibiting agent, and combinations thereof. |
| 地址 |
Hong Kong CN |
